Fed up of endless wait?
Look for clinic with Prime
Dr. Sharat Chandra Medical Oncologist in Hyderabad

Dr. Sharat Chandra

MBBS, DNB - Medical Oncology

Medical Oncologist
14 Years Experience Overall  (5 years as specialist)

Medical Registration Verified

Dr. Sharat Chandra is a Medical Oncologist in Lingampally, Hyderabad and has an experience of 14 years in this field. Dr. Sharat Chandra practices at American Oncology Institute in Lingampally, Hyderabad and Medicover Cancer Institute in Hitech City, Hyderabad. He completed MBBS from Dr. NTR University of Health Sciences Andhra Pradesh in 2011 and DNB - Medical Oncology from National Board of Examination, India in 2020. Some of the services provided by the doctor are: Head and Neck Tumor / Cancer Surgery,Melanoma Treatment,Stem Cell Transplantation,Breast Cancer Management and Chemotherapy of Haematological Malignancies etc.

Share your story

Lingampally, Hyderabad

American Oncology Institute

5.0

1-100/1/CCH, Nallagandla, Seri Lingampally, Landmark: Near Aparna Sarovar, Hyderabad

Get Directions

Mon - Sat

10:00 - 01:00

₹800

Common questions & answers

Q: Where does Dr. Sharat Chandra practice?

A: Dr. Sharat Chandra practices at American Oncology Institute - Lingampally.

Q: Why do patients visit Dr. Sharat Chandra?

A: Patients frequently visit Dr. Sharat Chandra for Head and Neck Tumor / Cancer Surgery, Melanoma Treatment, Stem Cell Transplantation. To see more reasons visit the doctor's profile on Practo.

Q: What is Dr. Sharat Chandra's education qualification?

A: Dr. Sharat Chandra has the following qualifications - MBBS, DNB - Medical Oncology.

Q: What does Dr. Sharat Chandra specialises in ?

A: Dr. Sharat Chandra specialises as Medical Oncologist.

Q: How many years of experience does Dr. Sharat Chandra have?

A: Dr. Sharat Chandra has an overall experience of 14 years. View where has Dr. Sharat Chandra practiced in the past.

Specializations

Medical Oncologist

Awards and Recognitions

Pathological response to weekly nabpaclitaxel and carboplatin followed by anthracycline regimen in triple negative breast cancer – ANNALS OF ONCOLOGY, Volume 31, Supplement 6, November 2020, Page S1253 G.Sharat Chandra, M.Singhal, D.Panda, A.Sharma,S.Vala
Shortcomings of immuno oncology (IO) agents application into real-world practise due to financial constraints in a resource constrained setting - ANNALS OF ONCOLOGY, Volume 31, Supplement 7, December 2020, Page S1436. G.Sharat Chandra, M.Singhal,A.Sharma,
Real-world data of incidence of immune related toxicities with single agent immuno oncology drugs at a single center - ANNALS OF ONCOLOGY, Volume 31, Supplement 7, December 2020, Page S1439 G.Sharat Chandra, M.Singhal, D.Panda, A.Sharma,S.Valame - https:/
A Prospective Study of Response Evaluation with RCHOP Therapy in DLBCL Subtypes using Hans Algorithm - Indian J Hematol Blood Transfusion (Nov 2020) 36(Suppl 1):S1–S229. Sharat Chandra G, Pratap Kishore Das,Manish singhal, Dipanjanpanda, Atul Sharma, Shau
A real-world scenario of applicability of immuno oncology agents into practice in NSCLC in a resource constrained setting – JOURNAL OF THORACIC ONCOLOGY, Vol. 16Issue 4S767–S768Published in issue: April, 2021. G.Sharat Chandra, M.Singhal,A.Sharma, S.Valam

Education

MBBS - Dr. NTR University of Health Sciences Andhra Pradesh, 2011
DNB - Medical Oncology - National Board of Examination, India, 2020

Registrations

APMC/FMR/75374 Telangana State Medical Council, 2012

Pick a time slot

Clinic Appointment
₹ 800 fee
American Oncology Institute
Change Clinic
5₹800
Lingampally